Linked Life Data

16259226

Source:http://linkedlifedata.com/resource/pubmed/id/16259226

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
pubmed:issue
10
pubmed:dateCreated
2005-11-1
pubmed:abstractText
DiaPep277, a 24-amino acid peptide based on residues 437 to 460 of heat shock protein 60, is undergoing phase II clinical trials by DeveloGen for the potential treatment and prevention of established and newly diagnosed type 1 diabetes symptoms of the prediabetic state and of latent autoimmune diabetes of the adult.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
1472-4472
pubmed:author
pubmed:issnType
Print
pubmed:volume
6
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1043-50
pubmed:dateRevised
2009-11-19
pubmed:meshHeading
pubmed:year
2005
pubmed:articleTitle
DiaPep277 (DeveloGen).
pubmed:affiliation
University of Pittsburgh School of Medicine, Diabetes Institute, Pittsburgh, PA 15213, USA. ngiann1@pitt.edu
pubmed:publicationType
Journal Article, Review